NEWS RELEASE
BARA·MED’s BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers
Southampton, PA. June 10, 2008. Environmental Tectonics Corporation’s (Amex: BARA·MED) (“BARA·MED” or the “Company”) BioMedical Systems division today announced the sale of seven BARA-MED® XD Monoplace Hyperbaric Chambers to Med One Capital for placement at four facilities associated with Haelen Hyperbarics.
BARA·MED is delighted to work with Haelen Hyperbarics, a growing network of physician operated Hyperbaric Oxygen Therapy (HBOT) clinics. Haelen Hyperbarics also provides physicians with turn-key HBOT solutions to incorporate the therapy into their existing medical practices throughout the United States.
BARA·MED prides itself on being the only manufacturer of a computerized monoplace hyperbaric chamber. The BARA-MED® XD includes a 4th generation Windows™ based operating system. This computerized system eliminates the need for operator dive time management and paper recordkeeping while ensuring comprehensive and unassailable documentation of the procedure. These features enable technicians to focus their attention on patient care and management, making them more effective and efficient.
Don Webber of BARA·MED’s BioMedical Division, commented, “We are happy with the sales we have experienced during our 1st fiscal quarter and are optimistic for continued sales growth in the coming year”.
The BioMedical Division plans to continue to supply its customers with both well-designed and scientifically advanced products in a competitive market. The BARA-MED and BARA-MED XD is a true evolution of our expertise in bringing practical value and technology closer together.
For further information on BARA·MED hyperbaric chambers and how our chambers could benefit your HBOT (Hyperbaric Oxygen Therapy) programs please visit our website http://www.etchyperbaricchambers.com.
Southampton, PA. June 10, 2008. Environmental Tectonics Corporation’s (Amex: BARA·MED) (“BARA·MED” or the “Company”) BioMedical Systems division today announced the sale of seven BARA-MED® XD Monoplace Hyperbaric Chambers to Med One Capital for placement at four facilities associated with Haelen Hyperbarics.
BARA·MED is delighted to work with Haelen Hyperbarics, a growing network of physician operated Hyperbaric Oxygen Therapy (HBOT) clinics. Haelen Hyperbarics also provides physicians with turn-key HBOT solutions to incorporate the therapy into their existing medical practices throughout the United States.
BARA·MED prides itself on being the only manufacturer of a computerized monoplace hyperbaric chamber. The BARA-MED® XD includes a 4th generation Windows™ based operating system. This computerized system eliminates the need for operator dive time management and paper recordkeeping while ensuring comprehensive and unassailable documentation of the procedure. These features enable technicians to focus their attention on patient care and management, making them more effective and efficient.
Don Webber of BARA·MED’s BioMedical Division, commented, “We are happy with the sales we have experienced during our 1st fiscal quarter and are optimistic for continued sales growth in the coming year”.
The BioMedical Division plans to continue to supply its customers with both well-designed and scientifically advanced products in a competitive market. The BARA-MED and BARA-MED XD is a true evolution of our expertise in bringing practical value and technology closer together.
For further information on BARA·MED hyperbaric chambers and how our chambers could benefit your HBOT (Hyperbaric Oxygen Therapy) programs please visit our website http://www.etchyperbaricchambers.com.
Forward-looking Statements
This news release contains forward-looking statements, which are based on management's expectations and are subject to uncertainties and changes in circumstances. Words and expressions reflecting something other than historical fact are intended to identify forward-looking statements, and these statements may include terminology such as "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "future", "predict", "potential", "intend", or "continue", and similar expressions. We base our forward-looking statements on our current expectations and projections about future events or future financial performance. Our forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about BARA·MED and its subsidiaries that may cause actual results to be materially different from any future results implied by these forward-looking statements. We caution you not to place undue reliance on these forward-looking statements.